Reviews	NNS
and	CC
prospectives	NNS
of	IN
signaling	NN
pathway	NN
analysis	NN
in	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
fibrosing	NN
disease	NN
with	IN
disappointing	JJ
survival	NN
rate	NN
,	,
and	CC
uneffective	JJ
therapeutic	JJ
progress	NN
has	VBZ
been	VBN
made	VBN
in	IN
the	DT
last	JJ
few	JJ
years	NNS
,	,
forcing	VBG
the	DT
urgent	JJ
need	NN
to	TO
improve	VB
research	NN
to	TO
this	DT
disease	NN
.	.

The	DT
commonly	RB
accepted	VBN
pathogenic	JJ
hypothesis	NN
of	IN
IPF	NN
is	VBZ
the	DT
trigger	NN
from	IN
continuous	JJ
alveolar	JJ
epithelium	NN
microinjuries	NNS
and	CC
in	IN
the	DT
following	VBG
series	NN
events	NNS
,	,
many	JJ
signaling	NN
pathways	NNS
were	VBD
reported	VBN
to	TO
lead	VB
to	TO
abnormal	JJ
tissue	NN
repair	NN
and	CC
lung	NN
structure	NN
derangement	NN
in	IN
IPF	NNP
,	,
such	JJ
as	IN
TGF-b	NN
,	,
wnt	NN
,	,
VEGF	NN
and	CC
PI3K-Akt	NN
signaling	NN
pathways	NNS
.	.

Traditional	JJ
research	NN
of	IN
IPF	NN
related	JJ
signaling	NN
pathway	NN
always	RB
focus	VB
on	IN
the	DT
independent	JJ
function	NN
of	IN
pathway	NN
and	CC
disease	NN
signals	NNS
,	,
but	CC
the	DT
crosstalks	NNS
and	CC
interactions	NNS
among	IN
them	PRP
were	VBD
rarely	RB
valued	VBN
.	.

In	IN
this	DT
review	NN
,	,
we	PRP
summarize	VBP
the	DT
signaling	NN
pathways	NNS
which	WDT
were	VBD
reported	VBN
to	TO
play	VB
important	JJ
roles	NNS
in	IN
the	DT
pathologic	JJ
changes	NNS
of	IN
IPF	NN
and	CC
the	DT
synergistic	JJ
effect	NN
among	IN
those	DT
pathways	NNS
.	.

Next	IN
we	PRP
discuss	VBP
the	DT
application	NN
of	IN
genomics	NNS
research	NN
and	CC
bioinformatics	NNS
tools	NNS
on	IN
IPF	NN
related	JJ
pathway	NN
analysis	NN
,	,
and	CC
give	VB
a	DT
systems	NNS
biology	NN
perspective	NN
by	IN
integrating	VBG
multi-level	JJ
disease	NN
related	JJ
data	NNS
.	.

The	DT
novel	JJ
prospective	JJ
of	IN
pathway	NN
analysis	NN
could	MD
tease	VB
out	RP
the	DT
complex	NN
pathway	NN
interaction	NN
profiles	NNS
of	IN
IPF	NN
,	,
and	CC
is	VBZ
powerful	JJ
to	TO
detect	VB
IPF	NN
related	JJ
biomarkers	NNS
for	IN
early	JJ
diagnose	VB
and	CC
potential	JJ
therapeutic	JJ
targets	NNS
.	.

